Skip to content
Catalyst

lactoferrinFinding

Lactoferrin decreases necrotising enterocolitis incidence

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Trial results show that lactoferrin supplementation to enteral feeds decreased late-onset sepsis (typical risk ratio (RR) 0.59, 95% confidence interval (CI) 0.40 to 0.87; typical risk difference (RD) -0.06, 95% CI -0.10 to -0.02; number needed to treat for an additional beneficial outcome (NNTB) 17, 95% CI 10 to 50; six trials, 886 participants; low-quality evidence) and NEC stage II or III (typical RR 0.40, 95% CI 0.18 to 0.86; typical RD -0.04, 95% CI -0.06 to -0.01; NNTB 25, 95% CI 17 to 100; four studies, 750 participants; low-quality evidence).”
Quoted verbatim from Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
This finding among the 8 findings on its endpoint

lactoferrin

Necrotising enterocolitis incidence

lowers

Effect as reported

0.4risk ratio

CI 0.18 to 0.86

Who
n = 750 · preterm neonates, lactoferrin added to enteral feeds (4 trials pooled); NEC counted at stage II or III
Dose studied
not reported

Very limited evidencePMID 28658720 · 2017

02 · The study

Study
meta-analysis
Participants
750
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7MA14YKQB33NMXWQGGAW9Y2